FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
April 26, 2024 at 07:02 AM EDT
The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
By:
CNBC.com News
April 26, 2024 at 07:02 AM EDT
The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|